Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Film producer Vikram Dhaktode arrested from the Tarri sets; Wife alleges an illicit affair with Priyanka Yadav Press Release
  • India’s First Choice For Every Health Enthusiast: The Ketogen Lean Smoothie Lifestyle
  • ICAI Luxembourg Successfully Hosts the 1st ICAI International Conference 2026 – Europe Business
  • Health Minister Rushikesh Patel inaugurates cardiology, IVF and high risk Obst units at Care and Cure Hospital Business
  • Paperex 2023, World’s Largest Paper Show, all set to showcase top brands and Latest Technology Business
  • Treatment Range Hospital Hosts Ayushmaan Bharat Camp in Bidar for Accessible Healthcare Health
  • Samson Brothers to lead Kochi Blue Tigers Sports
  • 24th Asian Business & Social Forum 2024, Dubai Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Welex Care Strengthens Its Commitment to Natural, Safe Health Care Solutions Health
  • Professor Dr. AK Dwivedi, nominated as Member of Executive Council of Devi Ahilya Vishwavidyalaya, Indore By Honourable Governer of MP Health
  • One Nation, One Day, One Million Blood Sugar Tests – Let’s Defeat Diabetes Health
  • B-Tex Ropes in Superstar Boman Irani as Brand Ambassador Health
  • Srimati Sirisha Raghavendra Garu Joins FitFourFreedom Success Celebration at Sravani Hospitals Health
  • Ravi Pharmaceuticals Marks 38 Years of Ayurvedic Excellence and Unveils Digital Innovation Health

Recent Posts

  • Know, Like, Trust (CCKLT) 4.0 Brings Together Delhi’s Business Community for an Evening of Leadership and Connection
  • Founder-Being LaunchPad: A 16-Week Venture-Building Program for Young Founders in Kochi
  • Lessons Worth Keeping: A Smarter Digital Toolkit for Teachers This Teachers’ Day
  • India’s Biggest Fashion Revolution: Lansky Mr Miss Mrs India World 2026–2027 Set to Crown Nation’s Next Global Icons as MD Yugank Sinhmar Unveils Historic Dubai Finale
  • Vinod Texworld Limited’s Rs.42.83 Crore IPO Opens from September 9 to September 11, 2026; Issue Price Fixed at Rs.94 Per Share

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Mellow showcased its natural range of products and gift hampers at Goa Business
  • Miles Education: Building Global Leaders Through the Certified Public Accountant Education
  • Beauty Kart, a beauty destination that filled the gap of beauty and authenticity in India A
  • Jamboree and GMAC Team Up to Boost Women’s Representation in Business Schools Education
  • Greenpanel Showcases Next-Generation Wood Panel Solutions at Bharat Buildcon 2026 Business
  • Royal Family of Hyderabad Kin Sahebzadi Maheen Rahman design Khada Dupatta for Times Fashion week Lifestyle
  • A Rotary District From India Starts Skilling Programs In Nutrition For African Health Workers Health
  • Supreme Court Lawyer Devesh Tripathi receives Honorary Doctorate from University of California. Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme